Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer

被引：0
|
作者：
Becky A. S. Bibby
Niluja Thiruthaneeswaran
Lingjian Yang
Ronnie R. Pereira
Elisabet More
Darragh G. McArt
Paul O’Reilly
Robert G. Bristow
Kaye J. Williams
Ananya Choudhury
Catharine M. L. West
机构：
[1] University of Manchester,Translational Radiobiology Group, Division of Cancer Science, School of Medical Sciences, Faculty of Biology, Medicine and Health
[2] Manchester Academic Health Sciences Centre,Sydney Medical School
[3] The Christie NHS Foundation Trust,Translational Oncogenomics
[4] University of Sydney,Centre for Cancer Research and Cell Biology
[5] CRUK Manchester Institute and CRUK Manchester Centre,School of Pharmacy and Pharmaceutical Sciences
[6] Queen’s University Belfast,undefined
[7] University of Manchester,undefined
来源：
BMC Urology | / 21卷
关键词：
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [1] Repurposing FDA approved drugs as radiosensitizers for treating hypoxic prostate cancer
    Bibby, Becky A. S.
    Thiruthaneeswaran, Niluja
    Yang, Lingjian
    Pereira, Ronnie R.
    More, Elisabet
    McArt, Darragh G.
    O'Reilly, Paul
    Bristow, Robert G.
    Williams, Kaye J.
    Choudhury, Ananya
    West, Catharine M. L.
    BMC UROLOGY, 2021, 21 (01)
  • [2] Repurposing of FDA-approved drugs as novel radiosensitisers in hypoxic prostate cancer
    Bibby, B.
    Thiruthaneeswaran, N.
    Yang, L.
    McArt, D.
    O'Reilly, P.
    Roberts, D.
    Choudhury, A.
    West, C.
    RADIOTHERAPY AND ONCOLOGY, 2018, 127 : S195 - S195
  • [3] Repurposing of FDA-approved Therapeutics to Identify Novel Radiosensitisers in Hypoxic Prostate Cancer
    Thiruthaneeswaran, N.
    Bibby, B. A. S.
    Yang, L.
    McArt, D.
    Choudhury, A.
    West, C.
    CLINICAL ONCOLOGY, 2018, 30 (03) : 195 - 196
  • [4] Repurposing of FDA-approved drugs against cancer - focus on metastasis
    Ozsvari, Bela
    Lamb, Rebecca
    Lisanti, Michael P.
    AGING-US, 2016, 8 (04): : 567 - 568
  • [5] Repurposing of FDA approved drugs for treatment of metastatic HNSCC
    Kondratyev, Maria
    Pesic, Aleksandra
    Dvorkin-Sheva, Anna
    Ketela, Troy
    Moffat, Jason
    Koritzinsky, Marianne
    Wouters, Brad
    CANCER RESEARCH, 2020, 80 (16)
  • [6] Repurposing approved drugs for cancer therapy
    Schein, Catherine H.
    BRITISH MEDICAL BULLETIN, 2021, 137 (01) : 13 - 27
  • [7] Repurposing FDA-approved drugs to target G-quadruplexes in breast cancer
    Moraca, Federica
    Arciuolo, Valentina
    Marzano, Simona
    Napolitano, Fabiana
    Castellano, Giuliano
    D'Aria, Federica
    Di Porzio, Anna
    Landolfi, Laura
    Catalanotti, Bruno
    Randazzo, Antonio
    Pagano, Bruno
    Malfitano, Anna Maria
    Amato, Jussara
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2025, 285
  • [8] Repurposing FDA-approved drugs as potential PARP inhibitors
    Eznarriaga, Maria
    Rahman, Taufiq
    BRITISH JOURNAL OF PHARMACOLOGY, 2020, 177 (11) : 2516 - 2516
  • [9] Repurposing FDA-approved drugs for anti-aging therapies
    Snell, Terry W.
    Johnston, Rachel K.
    Srinivasan, Bharath
    Zhou, Hongyi
    Gao, Mu
    Skolnick, Jeffrey
    BIOGERONTOLOGY, 2016, 17 (5-6) : 907 - 920
  • [10] Repurposing FDA-approved drugs for anti-aging therapies
    Terry W. Snell
    Rachel K. Johnston
    Bharath Srinivasan
    Hongyi Zhou
    Mu Gao
    Jeffrey Skolnick
    Biogerontology, 2016, 17 : 907 - 920
12345